Signaling pathways activated by oncogenic forms of Abl tyrosine kinase - PubMed (original) (raw)

Review

. 1999 Jun 25;274(26):18141-4.

doi: 10.1074/jbc.274.26.18141.

Affiliations

• PMID: 10373409
• DOI: 10.1074/jbc.274.26.18141

Free article

Review

Signaling pathways activated by oncogenic forms of Abl tyrosine kinase

X Zou et al. J Biol Chem. 1999.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways.
  Lim L, Manser E, Leung T, Hall C. Lim L, et al. Eur J Biochem. 1996 Dec 1;242(2):171-85. doi: 10.1111/j.1432-1033.1996.0171r.x. Eur J Biochem. 1996. PMID: 8973630 Review.
• Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding.
  Ting PY, Johnson CW, Fang C, Cao X, Graeber TG, Mattos C, Colicelli J. Ting PY, et al. FASEB J. 2015 Sep;29(9):3750-61. doi: 10.1096/fj.15-271510. Epub 2015 May 21. FASEB J. 2015. PMID: 25999467 Free PMC article.
• Rac is required for v-Abl tyrosine kinase to activate mitogenesis.
  Renshaw MW, Lea-Chou E, Wang JY. Renshaw MW, et al. Curr Biol. 1996 Jan 1;6(1):76-83. doi: 10.1016/s0960-9822(02)00424-4. Curr Biol. 1996. PMID: 8805224
• Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases.
  Zou X, Rudchenko S, Wong K, Calame K. Zou X, et al. Genes Dev. 1997 Mar 1;11(5):654-62. doi: 10.1101/gad.11.5.654. Genes Dev. 1997. PMID: 9119229
• JAK-STAT signaling activated by Abl oncogenes.
  Danial NN, Rothman P. Danial NN, et al. Oncogene. 2000 May 15;19(21):2523-31. doi: 10.1038/sj.onc.1203484. Oncogene. 2000. PMID: 10851051 Review.

Cited by

• Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.
  Yi CR, Rosenberg N. Yi CR, et al. J Virol. 2007 Sep;81(17):9461-8. doi: 10.1128/JVI.00735-07. Epub 2007 Jun 27. J Virol. 2007. PMID: 17596313 Free PMC article.
• NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.
  Nakamura Y, Grumont RJ, Gerondakis S. Nakamura Y, et al. Mol Cell Biol. 2002 Aug;22(15):5563-74. doi: 10.1128/MCB.22.15.5563-5574.2002. Mol Cell Biol. 2002. PMID: 12101248 Free PMC article.
• Reovirus as a novel oncolytic agent.
  Norman KL, Lee PW. Norman KL, et al. J Clin Invest. 2000 Apr;105(8):1035-8. doi: 10.1172/JCI9871. J Clin Invest. 2000. PMID: 10772645 Free PMC article. No abstract available.
• Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients.
  Mir R, Ah I, Javid J, Zuberi M, Guru S, Mirza M, Farooq S, Yadav P, Ray PC, Gupta N, Saxena A. Mir R, et al. World J Oncol. 2015 Apr;6(2):321-328. doi: 10.14740/wjon912e. Epub 2015 Apr 12. World J Oncol. 2015. PMID: 29147425 Free PMC article.
• Cancer cell signaling pathways targeted by spice-derived nutraceuticals.
  Sung B, Prasad S, Yadav VR, Aggarwal BB. Sung B, et al. Nutr Cancer. 2012;64(2):173-97. doi: 10.1080/01635581.2012.630551. Epub 2011 Dec 9. Nutr Cancer. 2012. PMID: 22149093 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal